Your browser doesn't support javascript.
loading
Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data.
Kluberg, Sheryl A; Hou, Laura; Dutcher, Sarah K; Billings, Monisha; Kit, Brian; Toh, Sengwee; Dublin, Sascha; Haynes, Kevin; Kline, Annemarie; Maiyani, Mahesh; Pawloski, Pamala A; Watson, Eric S; Cocoros, Noelle M.
Afiliação
  • Kluberg SA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Hou L; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Dutcher SK; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Billings M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Kit B; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Dublin S; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Haynes K; HealthCore, Inc., Wilmington, Delaware, USA.
  • Kline A; CVS Health Clinical Trial Services (formerly known as Healthagen), Affiliate of Aetna and Part of CVS Health family of companies, Blue Bell, Pennsylvania, USA.
  • Maiyani M; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
  • Pawloski PA; HealthPartners, Bloomington, Minnesota, USA.
  • Watson ES; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
  • Cocoros NM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Pharmacoepidemiol Drug Saf ; 31(4): 476-480, 2022 04.
Article em En | MEDLINE | ID: mdl-34913208

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article